2021 European Heart Rhythm Association Practical Guide on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation | Europace | 2021 | 99 |
Dapagliflozin and the Incidence of Type 2 Diabetes in Patients With Heart Failure and Reduced Ejection Fraction: An Exploratory Analysis From DAPA-HF | Diabetes Care | 2021 | 24 |
2021 Focused Update Consensus Guidelines of the Asia Pacific Heart Rhythm Society on Stroke Prevention in Atrial Fibrillation: Executive Summary | Thrombosis and Haemostasis | 2021 | 16 |
Dapagliflozin and Recurrent Heart Failure Hospitalizations in Heart Failure With Reduced Ejection Fraction: An Analysis of DAPA-HF | Circulation | 2021 | 13 |
Telemedicine in the management of hypertension: Evolving technological platforms for blood pressure telemonitoring | Journal of Clinical Hypertension | 2021 | 13 |
Development of flexible electrochemical impedance spectroscopy-based biosensing platform for rapid screening of SARS-CoV-2 inhibitors | Biosensors and Bioelectronics | 2021 | 12 |
Assessment of preferred methods to measure insulin resistance in Asian patients with hypertension | Journal of Clinical Hypertension | 2021 | 12 |
Guidance on ambulatory blood pressure monitoring: A statement from the HOPE Asia Network | Journal of Clinical Hypertension | 2021 | 10 |
Non-vitamin K antagonist oral anticoagulants and warfarin in atrial fibrillation patients with concomitant peripheral artery disease | European Heart Journal - Cardiovascular Pharmacotherapy | 2021 | 10 |
Rhodiola crenulata reduces ventricular arrhythmia through mitigating the activation of IL-17 and inhibiting the MAPK signaling pathway | Cardiovascular Drugs and Therapy | 2021 | 9 |
Income level and outcomes in patients with heart failure with universal health coverage | Heart | 2021 | 9 |
Non-Vitamin K Antagonist Oral Anticoagulants in Elderly (≥85 years) Patients With Newly Diagnosed Atrial Fibrillation: Changing Clinical Practice and Outcomes for Stroke Prevention in a Nationwide Cohort Study | Mayo Clinic Proceedings | 2021 | 9 |
2021 Focused update of the 2017 consensus guidelines of the Asia Pacific Heart Rhythm Society (APHRS) on stroke prevention in atrial fibrillation | Journal of Arrhythmia | 2021 | 8 |
Gal-1 (Galectin-1) Upregulation Contributes to Abdominal Aortic Aneurysm Progression by Enhancing Vascular Inflammation | Arteriosclerosis, Thrombosis, and Vascular Biology | 2021 | 7 |
Recent Progress in Metabolic Syndrome Research and Therapeutics | International Journal of Molecular Sciences | 2021 | 7 |
The association of the steatosis severity in fatty liver disease with coronary plaque pattern in general population | Liver International | 2021 | 7 |
Hyperuricemia induces endothelial dysfunction and accelerates atherosclerosis by disturbing the asymmetric dimethylarginine/dimethylarginine dimethylaminotransferase 2 pathway | Redox Biology | 2021 | 7 |
Gender difference in the association between TyG index and subclinical atherosclerosis: results from the I-Lan Longitudinal Aging Study | Cardiovascular Diabetology | 2021 | 6 |
Effectiveness and Safety of Direct Oral Anticoagulants in an Asian Population with Atrial Fibrillation Undergoing Dialysis: A Population-Based Cohort Study and Meta-Analysis | Cardiovascular Drugs and Therapy | 2021 | 6 |
Continuation or discontinuation of oral anticoagulants after HAS-BLED scores increase in patients with atrial fibrillation | Clinical Research in Cardiology | 2021 | 6 |
Enhanced detection of cardiac arrhythmias utilizing 14-day continuous ECG patch monitoring | International Journal of Cardiology | 2021 | 6 |
Angiotensin receptor neprilysin inhibitor as a novel antihypertensive drug: Evidence from Asia and around the globe | Journal of Clinical Hypertension | 2021 | 6 |
Disaster hypertension and cardiovascular events in disaster and COVID-19 pandemic | Journal of Clinical Hypertension | 2021 | 6 |
Clinical significance of nocturnal home blood pressure monitoring and nocturnal hypertension in Asia | Journal of Clinical Hypertension | 2021 | 6 |
Efficacy of dapagliflozin in heart failure with reduced ejection fraction according to body mass index | European Journal of Heart Failure | 2021 | 6 |